Location- and ADC-based stratification of transition zone PI-RADS 3 lesions to optimize biopsy indication

Le résumé fourni par la source

PURPOSE: To determine whether anatomical location and apparent diffusion coefficient (ADC) risk stratification optimizes biopsy selection for PI-RADS 3 lesions in the transition zone (TZ). METHODS: This retrospective single-center study included 218 TZ PI-RADS 3 lesions in 128 patients who underwent radical prostatectomy between January 2014 and September 2023. Two radiologists identified 218 TZ PI-RADS 3 lesions in 128 patients on MRI and measured mean ADC; a third radiologist correlated imaging findings with whole-mount histopathology. Lesions located in the anterior apex, anterior mid-gland, or middle apex were classified as Location-risk positive; lesions with mean ADC < 0.800 × 10⁻³ mm²/s were classified as ADC-risk positive. Four virtual biopsy strategies were compared (conventional, Location-based, ADC-based, and Location + ADC-based). Outcomes included cancer detection rate (CDR), biopsy burden (performed/avoided), clinically significant prostate cancer (csPCa) yield (detected/missed), positive predictive value (PPV), and net benefit on decision curve analysis (thresholds, 5-25%). RESULTS: Mean age was 68 ± 5.9 years (median, 69; range, 50-78). Among 218 lesions, 34 (16%) were csPCa. CDR was higher in location-risk positive than negative lesions (43% [28/65] vs. 4% [6/153]; p < 0.001) and in ADC-risk positive than ADC-risk negative lesions (47% [15/32] vs. 10% [19/186]; p < 0.001). Compared with conventional biopsy, the Location + ADC-based strategy reduced biopsies by 62% while detecting 31 of 34 csPCa lesions (91%) and missing 3 of 34 csPCa lesions (9%). Both location-informed strategies showed higher net benefit than the conventional across the evaluated thresholds. CONCLUSION: For TZ PI-RADS 3 lesions, combining anatomical location with an ADC threshold reduces unnecessary biopsies while preserving csPCa detection.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.